REG - Barclays PLC Quanex Building Prod - Form 8.3 - Quanex Building Products Corporation
24/04/2024 14:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240424:nRSX9027La&default-theme=true
RNS Number : 9027L Barclays PLC 24 April 2024
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose QUANEX BUILDING PRODUCTS CORP
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 23 Apr 2024
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? TYMAN PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: Common
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 30,601 0.09% 7,828 0.02%
(2) Cash-settled derivatives:
and/or controlled: 2,650 0.01% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 33,251 0.10% 7,828 0.02%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
Common Purchase 72,642 34.5779 USD
Common Purchase 9,464 34.7500 USD
Common Purchase 9,391 34.5292 USD
Common Purchase 6,347 34.3816 USD
Common Purchase 5,651 34.3767 USD
Common Purchase 5,403 34.5774 USD
Common Purchase 3,119 34.7531 USD
Common Purchase 1,037 34.7380 USD
Common Purchase 406 34.4686 USD
Common Purchase 288 34.7900 USD
Common Purchase 251 34.5942 USD
Common Purchase 201 33.7900 USD
Common Purchase 115 34.7343 USD
Common Purchase 100 34.1770 USD
Common Purchase 100 34.8500 USD
Common Purchase 67 34.4995 USD
Common Purchase 42 34.5600 USD
Common Purchase 38 34.7100 USD
Common Purchase 31 34.7045 USD
Common Purchase 19 34.7747 USD
Common Purchase 10 34.3400 USD
Common Purchase 9 34.2800 USD
Common Purchase 9 34.1333 USD
Common Purchase 8 34.5150 USD
Common Purchase 4 34.3600 USD
Common Purchase 4 34.4600 USD
Common Purchase 2 34.7200 USD
Common Purchase 1 34.7400 USD
Common Purchase 1 34.8700 USD
Common Purchase 1 34.7600 USD
Common Sale 24,295 34.6062 USD
Common Sale 22,589 34.6115 USD
Common Sale 14,547 34.4857 USD
Common Sale 9,392 34.4318 USD
Common Sale 7,962 34.7500 USD
Common Sale 4,401 34.5489 USD
Common Sale 4,200 34.5694 USD
Common Sale 4,200 34.5363 USD
Common Sale 2,986 34.4259 USD
Common Sale 1,800 34.6675 USD
Common Sale 1,332 34.5880 USD
Common Sale 1,199 34.3508 USD
Common Sale 1,100 34.4927 USD
Common Sale 1,085 34.4700 USD
Common Sale 1,001 34.5501 USD
Common Sale 976 34.3917 USD
Common Sale 900 34.4711 USD
Common Sale 799 34.7935 USD
Common Sale 706 34.5821 USD
Common Sale 700 34.6828 USD
Common Sale 677 34.4654 USD
Common Sale 661 34.4206 USD
Common Sale 484 34.4895 USD
Common Sale 371 34.1602 USD
Common Sale 300 34.5366 USD
Common Sale 205 34.3300 USD
Common Sale 201 34.8498 USD
Common Sale 201 34.3392 USD
Common Sale 200 34.7350 USD
Common Sale 115 34.7343 USD
Common Sale 102 34.7400 USD
Common Sale 100 34.5000 USD
Common Sale 100 34.5900 USD
Common Sale 31 34.7045 USD
Common Sale 24 34.5554 USD
Common Sale 20 34.6200 USD
Common Sale 14 34.3457 USD
Common Sale 13 34.6900 USD
Common Sale 10 34.4075 USD
Common Sale 10 34.7150 USD
Common Sale 7 34.7100 USD
Common Sale 6 34.7833 USD
Common Sale 5 34.7300 USD
Common Sale 4 34.7650 USD
Common Sale 2 34.7200 USD
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 Apr 2024
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETEADLLADELEFARecent news on Barclays
See all newsREG - Barclays PLC Tyman PLC - Form 8.3 - TYMAN PLC
AnnouncementREG - Barclays PLC Smith (DS) PLC - Form 8.3 - DS SMITH PLC
AnnouncementREG - Barclays PLC Lok'nStore Group - Form 8.3 - LOK'NSTORE GROUP PLC
AnnouncementREG - Barclays PLC Mattioli Woods PLC - Form 8.3 - MATTIOLI WOODS PLC
AnnouncementREG - Barclays PLC Hipgnosis Songs Fund - Form 8.3 - HIPGNOSIS SONGS FUND LTD
Announcement